Current Report Filing (8-k)

Date : 09/24/2019 @ 10:06AM
Source : Edgar (US Regulatory)
Stock : Protagenic Therapeutics, Inc. (QB) (PTIX)
Quote : 2.0  0.0 (0.00%) @ 7:31PM

Current Report Filing (8-k)

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of Earliest Event Reported): September 23, 2019  

 

PROTAGENIC THERAPEUTICS, INC.
(Exact name of Company as specified in its charter)

 

Delaware   000-51353   06-1390025

(State or other jurisdiction

of incorporation)

 

(Commission

File Number)

 

(I.R.S. Employer

Identification No.)

 

149 Fifth Avenue, Suite 500, New York, NY   10010
(Address of principal executive offices)   (Zip Code)

 

212-994-8200

 

(Company’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Company under any of the following provisions:

 

[  ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
[  ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
[  ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
[  ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Ticker symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. [  ]

 

 

 

   

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

Protagenic Therapeutics, Inc. (the “Company”) held its 2019 Annual Meeting of Stockholders (the “Annual Meeting”) on September 23, 2019. Holders of an aggregate of 10,261,419 shares of the Company’s Common Stock at the close of business on July 30, 2019 were entitled to vote at the Annual Meeting, of which 5,544,957 shares were present in person or represented by proxy. At the Annual Meeting, the Company’s stockholders voted as follows:

 

Proposal One: The stockholders elected each of the following individuals as a director for a one year term expiring on the date of the Company’s 2020 Annual Meeting of Stockholders and until their successors have been duly elected and qualified.

 

Name   For     Against     Withheld     Broker Non-Votes  
Garo H. Armen     5,433,802       0       109       -  
Robert B. Stein     5,433,801       0       110       -  
Khalil Barrage     5,433,011       0       900       -  
Brian J. Corvese     5,433,812       0       99       -  
Josh Silverman     5,433,013       0       898       -  

 

Proposal Two: The stockholders ratified the selection of MaloneBailey LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2019.

 

For   Against   Abstain
5,544,387   556   14

 

  2  

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PROTAGENIC THERAPEUTICS, INC.
     
Date: September 24, 2019 By: /s/ Alexander K. Arrow
  Name: Alexander K. Arrow
  Title: Chief Financial Officer

 

  3  

 

 

Protagenic Therapeutics, Inc. (USOTC:PTIX)
Historical Stock Chart

1 Year : From Dec 2018 to Dec 2019

Click Here for more Protagenic Therapeutics, Inc. Charts.

Protagenic Therapeutics, Inc. (USOTC:PTIX)
Intraday Stock Chart

Today : Friday 13 December 2019

Click Here for more Protagenic Therapeutics, Inc. Charts.

Latest PTIX Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts


Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.


NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.